Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Sarker, Debashis
Pedicona, Federico
Zen, Yoh
Borek, Weronika E.
Khorsandi, Shirin Elizabeth
Christopher, Josie
Karampera, Christina
Dowe, Thomas
Heaton, Nigel
Cutillas, Pedro Rodriguez
Dokal, Arran David
Britton, David James
机构：
[1] Kings Coll London, London, England
[2] Kinom Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Kings Coll Hosp London, Inst Liver Studies, London, England
[5] Kings Coll Hosp London, London, England
[6] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15155
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Protein Biomarkers serve as a signature for Hepatocellular carcinoma (HCC)
    Reau, Nancy
    Schabacker, Daniel
    Barder, Timothy
    Lee, Sang Mee
    Randall, Glenn
    Jensen, Donald M.
    HEPATOLOGY, 2012, 56 : 487A - 488A
  • [23] Biomarkers for virus-induced hepatocellular carcinoma (HCC)
    Mathew, Shilu
    Ali, Ashraf
    Abdel-Hafiz, Hany
    Fatima, Kaneez
    Suhail, Mohd
    Archunan, Govindaraju
    Begum, Nargis
    Jahangir, Syed
    Ilyas, Muhammad
    Chaudhary, Adeel G. A.
    Al Qahtani, Mohammad
    Bazarah, Salem Mohamad
    Qadri, Ishtiaq
    INFECTION GENETICS AND EVOLUTION, 2014, 26 : 327 - 339
  • [24] Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
    Hu, Xiaoyi
    Bao, Mingyang
    Huang, Jiacheng
    Zhou, Lin
    Zheng, Shusen
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis
    Xia, Qianlin
    Li, Zehuan
    Zheng, Jianghua
    Zhang, Xu
    Di, Yang
    Ding, Jin
    Yu, Die
    Yan, Li
    Shen, Longqiang
    Yan, Dong
    Jia, Ning
    Chen, Weiping
    Feng, Yanling
    Wang, Jin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 4851 - 4863
  • [26] Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib: A single institution experience
    Abdel-Rahman, Omar
    Lamarca, Angela
    Salu, Ismail
    McNamara, Mairead G.
    Valle, Juan W.
    Hubner, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [27] Protein Biomarkers Reactive With Hepatocellular Carcinoma (HCC) Sera Serve As a Signature for Hepatocellular Carcinoma
    Reau, Nancy
    Bissonnette, Marc
    Barder, Timothy J.
    Schabacker, Daniel
    Forrester, Sara
    Jensen, Donald M.
    GASTROENTEROLOGY, 2015, 148 (04) : S1023 - S1023
  • [28] Exposure of Bisphenols (BPs) to hepatocellular carcinoma (HCC) patients and non-HCC patients: Association with liver function biomarkers
    Li, Shibo
    Li, Yanjie
    Deng, Yun
    Wang, Fei
    Chen, Da
    Lu, Bin
    Lin, Nan
    EMERGING CONTAMINANTS, 2024, 10 (04)
  • [29] Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
    Llovet, Josep M.
    Pena, Carol E. A.
    Lathia, Chetan D.
    Shan, Michael
    Meinhardt, Gerold
    Bruix, Jordi
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2290 - 2300
  • [30] PROTEIN BIOMARKERS REACTIVE WITH HCC SERA SERVE AS A SIGNATURE FOR HEPATOCELLULAR CARCINOMA (HCC)
    Reau, N. S.
    Bissonnette, M.
    Forrester, S.
    Schabacker, D.
    Barder, T.
    Jensen, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S443 - S443
12345